These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33615705)

  • 1. A correlation study of mismatch repair immunohistochemical protein expression of pancreatic solid tumors in cytology cell blocks and matching surgical specimens.
    Teodosescu A; Chan I; Elder J; Wu M
    Diagn Cytopathol; 2021 Jun; 49(6):700-705. PubMed ID: 33615705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma.
    Mettman D; Haer E; Olyaee M; Rastogi A; Madan R; O'Neil M; Kelting S; Dennis K; Fan F
    Ann Diagn Pathol; 2020 Aug; 47():151552. PubMed ID: 32570025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.
    Ahmad-Nielsen SA; Bruun Nielsen MF; Mortensen MB; Detlefsen S
    Pathol Res Pract; 2020 Jun; 216(6):152985. PubMed ID: 32360245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of immunohistochemical mismatch repair protein status between colorectal carcinoma endoscopic biopsy and resection specimens.
    O'Brien O; Ryan É; Creavin B; Kelly ME; Mohan HM; Geraghty R; Winter DC; Sheahan K
    J Clin Pathol; 2018 Jul; 71(7):631-636. PubMed ID: 29419411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
    McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R
    J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Furuhata A; Minamiguchi S; Shirahase H; Kodama Y; Adachi S; Sakurai T; Haga H
    Pancreas; 2017 Apr; 46(4):531-538. PubMed ID: 28099249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Maspin, CK17 and Ki-67 Immunophenotyping in Diagnosing of Pancreatic Ductal Adenocarcinoma in Endoscopic Ultrasound-Guided Fine Needle Aspiration Cytology.
    Mamdouh MM; Okasha H; Shaaban HAM; Hafez NH; El-Gemeie EH
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3299-3307. PubMed ID: 34711007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients with Pancreatic Ductal Adenocarcinoma (PDAC).
    Constantin A; Iovănescu V; Cazacu IM; Ungureanu BS; Copăescu C; Stroescu C; Bejinariu N; Săftoiu A
    Diagnostics (Basel); 2022 Jan; 12(2):. PubMed ID: 35204385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistological evaluation of mismatch repair deficiency in pancreatic ductal adenocarcinoma treated with surgical resection.
    Otsuka H; Murakami Y; Uemura K; Kondo N; Nakagawa N; Okada K; Seo S; Takahashi S
    J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):421-428. PubMed ID: 32219999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic utility of methylthioadenosine phosphorylase immunohistochemistry for pancreatic ductal adenocarcinoma in FNA and small biopsy specimens.
    Yu S; Doyle LA; Hornick JL; Mito JK
    Cancer Cytopathol; 2024 Feb; 132(2):87-95. PubMed ID: 38054349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
    Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
    World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.
    Wang T; Stadler ZK; Zhang L; Weiser MR; Basturk O; Hechtman JF; Vakiani E; Saltz LB; Klimstra DS; Shia J
    Fam Cancer; 2018 Apr; 17(2):225-228. PubMed ID: 28819720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations.
    Hu ZI; Shia J; Stadler ZK; Varghese AM; Capanu M; Salo-Mullen E; Lowery MA; Diaz LA; Mandelker D; Yu KH; Zervoudakis A; Kelsen DP; Iacobuzio-Donahue CA; Klimstra DS; Saltz LB; Sahin IH; O'Reilly EM
    Clin Cancer Res; 2018 Mar; 24(6):1326-1336. PubMed ID: 29367431
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples?
    Shia J; Stadler Z; Weiser MR; Rentz M; Gonen M; Tang LH; Vakiani E; Katabi N; Xiong X; Markowitz AJ; Shike M; Guillem J; Klimstra DS
    Am J Surg Pathol; 2011 Mar; 35(3):447-54. PubMed ID: 21297438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma.
    Tessier-Cloutier B; Kalloger SE; Al-Kandari M; Milne K; Gao D; Nelson BH; Renouf DJ; Sheffield BS; Schaeffer DF
    BMC Cancer; 2017 Sep; 17(1):618. PubMed ID: 28870260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
    Zakout YM; Lanza G
    J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100P and XIAP expression in pancreatic ductal adenocarcinoma: potential novel biomarkers as a diagnostic adjunct to fine needle aspiration cytology.
    Kosarac O; Takei H; Zhai QJ; Schwartz MR; Mody DR
    Acta Cytol; 2011; 55(2):142-8. PubMed ID: 21325798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of endoscopic ultrasound-guided fine-needle aspiration and biopsy with 22-gauge and 25-gauge needles for the "precision medicine" of pancreatic cancer: A retrospective study.
    Yoshizawa N; Yamada R; Sakuno T; Inoue H; Miura H; Takeuchi T; Nakamura M; Hamada Y; Katsurahara M; Tanaka K; Horiki N; Takei Y
    Medicine (Baltimore); 2018 Jun; 97(24):e11096. PubMed ID: 29901627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus impacts on expression of DNA mismatch repair protein PMS2 and tumor microenvironment in pancreatic ductal adenocarcinoma.
    Pan X; Mizukami H; Hara Y; Yamada T; Yamazaki K; Kudoh K; Takeuchi Y; Sasaki T; Kushibiki H; Igawa A; Hakamada K
    J Diabetes Investig; 2023 Jan; 14(1):132-144. PubMed ID: 36453157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.